ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS)


$0.24
+0.0073 ( +3.21% ) 876.7K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$0.24

Previous close


$0.23

Volume


876.7K

Market cap


$5.49M

Day range


$0.21 - $0.24

52 week range


$0.14 - $1.66

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 21 Jul 09, 2024
8-k 8K-related 16 May 20, 2024
10-q Quarterly Reports 60 May 15, 2024
8-k 8K-related 13 Apr 10, 2024
8-k 8K-related 15 Apr 10, 2024
8-k 8K-related 15 Apr 04, 2024
10-k Annual reports 88 Apr 01, 2024
8-k 8K-related 14 Feb 26, 2024
def Proxies and info statements 6 Jan 24, 2024
8-k 8K-related 13 Jan 18, 2024

Latest News